PT  - JOURNAL ARTICLE
AU  - Verwilt, Jasper
AU  - Hellemans, Jan
AU  - Sante, Tom
AU  - Mestdagh, Pieter
AU  - Vandesompele, Jo
TI  - Evaluation of efficiency and sensitivity of 1D and 2D sample pooling strategies for SARS-CoV-2 RT-qPCR screening purposes
AID  - 10.1101/2020.07.17.20152702
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.07.17.20152702
4099  - http://medrxiv.org/content/early/2021/09/10/2020.07.17.20152702.short
4100  - http://medrxiv.org/content/early/2021/09/10/2020.07.17.20152702.full
AB  - To increase the throughput, lower the cost, and save scarce test reagents, laboratories can pool patient samples before SARS-CoV-2 RT-qPCR testing. While different sample pooling methods have been proposed and effectively implemented in some laboratories, no systematic and large-scale evaluations exist using real-life quantitative data gathered throughout the different epidemiological stages. Here, we use anonymous data from 9673 positive cases to simulate and compare 1D and 2D pooling strategies. We show that the optimal choice of pooling method and pool size is an intricate decision with a testing population-dependent efficiency-sensitivity trade-off and present an online tool to provide the reader with custom real-time pooling strategy recommendations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received. The data of the RT-qPCR tests was provided by Biogazelle.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Commissie voor Medische Ethiek UGent/UZ GentAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code and Cq values are available on https://github.com/OncoRNALab/covidpooling. https://github.com/OncoRNALab/covidpooling